Navigation Links
Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer
Date:2/24/2011

7).

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. As a specialty pharmaceutical company, Bayer HealthCare Pharmaceuticals provides products for Diagnostic Imaging, General Medicine, Hematology, Neurology, Oncology and Women's Healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer.  The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(r) (sorafenib) tablets, a small molecule drug that is currently approved for the treatment of liver cancer and advanced kidney cancer.  Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types.  Beyond Nexavar, Onyx has established a development pipeline of anticancer compounds at various stages of clinical testing, including carfilzomib, a next generation proteasome inhibitor, that is currently being evaluated in multiple clinical trials for the treatment of patients with relapsed or relapsed/refractory multiple myeloma and solid tumors.  ONX 0801, an alpha-folate receptor targeted inhibitor of the thymidylate synthase, and ONX 0912, an oral proteasome inhibitor, are currently in Phase 1 testing.  For more information about Onyx, visit the company's website at www.onyx-pharm.com.

Forward Looking Statements

This
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... NEW YORK and VIENNA , ... today at a press conference in New York ... of PD01A, a vaccine against Parkinson,s disease. PD01A is the ... target, to enter clinical testing. The Michael J. ... a $ 1.5 million grant, and presented at the press ...
(Date:7/31/2014)... LONDON , July 31, 2014 genae, ... medical industries, announced today the incorporation of genae UK in ... has one of the largest medical device markets in ... and it is projected to increase by a CAGR of 6.0% ... 2012, equal to 9.5% of GDP. Despite recessionary pressures, market growth ...
(Date:7/31/2014)... 2014 Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics ... a conference call on Thursday, August 14, 2014, at 4:30 ... ended June 30, 2014. Financial results will be issued in ... Chairman, President and CEO James LaFrance will host ... Date: Thursday, August 14, 2014 Time: 4:30 p.m. Eastern ...
Breaking Medicine Technology:First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4genae Opens Offices in London 2Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2
... Oct. 14 Cephalon, Inc. (Nasdaq: CEPH ... Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) ... Administration (FDA).  The GABITRIL REMS consists of a Medication ... with the use of GABITRIL.  The implementation of the ...
... SMA ), a leading independent provider of products ... announced today that it will release third quarter 2010 financial ... market opens on Thursday, November 4, 2010. Symmetry Medical will ... Thursday, November 4, 2010. A live Web ...
Cached Medicine Technology:Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL 2Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL 3Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL 4Symmetry Medical to Report Third Quarter 2010 Financial Results on November 4, 2010 2
(Date:7/31/2014)... Adventist Health System, which is ... Florida Hospital Tampa, Florida Hospital Carrollwood, Florida Hospital ... Pinellas, Florida Hospital Wesley Chapel, Florida Hospital Zephyrhills, ... Heartland Medical Center Lake Placid and Florida Hospital ... Most Wired Hospitals and Health Systems, which is ...
(Date:7/31/2014)... 2014 Hook Your Ex, a system created by ... feel emotionally hungry for their partner, to the point of starvation, ... little trick has been taught to hundreds of men and women ... Hook Your Ex review , Shane Michaels agrees this simple trick ... a breakup a second chance at getting back together with their ...
(Date:7/31/2014)... 31, 2014 United Theological Seminary is ... Anthony Le Donne and Peter J. Bellini. Both began ... to United is a Director of Non-Degree Programs, Mark ... , Anthony Le Donne, Assistant Professor of New Testament, ... teaches New Testament, Second Temple Judaism, and Greek courses. ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Cosmetic Town ... best Plastic Surgeons to consumers considering cosmetic treatments. ... their peers whose goal is to educate prospective patients ... are selected through a validated referral system that helps ... the best in their respective fields. , Cosmetic ...
(Date:7/31/2014)... The VitaSleep FDA cleared anti-snoring device ... an easier breathing capacity by slightly adjusting the position ... can breathe easier and helps reduce or even completely ... it can meet the needs of each individual snorer. ... by actual customer reviews. Johathan R. from Statham ...
Breaking Medicine News(10 mins):Health News:Florida Hospital West Florida Region is Among the Most Wired Hospitals and Health Systems in the United States 2Health News:Hook Your Ex Review by Shane Michaels Exposes Steve Pratt And His New Method For Getting Back With The Ex 2Health News:Growing Seminary Welcomes New Faculty 2Health News:The New Doctors’ Directory, Cosmetic Town Does the Research for Consumers of Plastic Surgeries 2Health News:New Dental Device Reviews to Stop Snoring by VitalSleep 2
... 2011) The Lymphoma Division of the John Theurer Cancer ... the Facebook groups "Hope for Lymphoma" and "Our MCL Family," ... November 12 from 8:30am 3:45pm. The event is ... Lymphoma (MCL) patients and their caregivers coping with this challenging ...
... EDITOR,S PICK: Connexins: providing protection to cells destroyed in ... a lifelong disease characterized by high levels of sugar ... patient,s immune system attacking and destroying the cells in ... blood glucose levels. Surprisingly, little is known about the ...
... , MONDAY, Nov. 7 (HealthDay News) -- People who believe ... it than those who think the rule has some wiggle room, ... a number of human behaviors and actions, including the Arab Spring ... in an upcoming issue of the journal Psychological Science . ...
... be published online Nov. 6 in Nature Medicine , ... that the development of osteoarthritis is in great part driven ... prevailing view attributing the condition to a lifetime of wear ... said William Robinson, MD, PhD, the study,s senior author, of ...
... Ore. After men become fathers for the first time, ... according to a new, 19-year study. Researchers assessed more ... to 31, and examined how men,s crime, tobacco, alcohol, and ... marriage can change a man,s negative behavior, they had not ...
... undergo radical prostatectomy get better results at teaching hospitals ... of an international study led by researchers at Henry ... that teaching hospitals always provide better care than others, ... characteristics that would explain the better results," says Quoc-Dien ...
Cached Medicine News:Health News:John Theurer Cancer Center to host inaugural Mantle Cell Lymphoma Symposium 2Health News:John Theurer Cancer Center to host inaugural Mantle Cell Lymphoma Symposium 3Health News:JCI online early table of contents: Nov. 7, 2011 2Health News:JCI online early table of contents: Nov. 7, 2011 3Health News:JCI online early table of contents: Nov. 7, 2011 4Health News:JCI online early table of contents: Nov. 7, 2011 5Health News:JCI online early table of contents: Nov. 7, 2011 6Health News:People Seem More Likely to Follow Rules They Can't Beat 2Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 2Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 3Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 4Health News:Fatherhood can help change a man's bad habits 2Health News:Prostate cancer surgery better at teaching hospitals 2
Ties improve torso fit and transfer weight to waist and hips. Ties are 1"W cotton woven for flexibility and sewn at an angle across the full width of the two back sections for durability....
Ties improve torso fit and transfer weight to waist and hips. Ties are 1"W cotton woven for flexibility and sewn at an angle across the full width of the two back sections for durability....
Hip-hugging design transfers weight from shoulders to the hips. Crisscross shoulder design provides snug and comfortable upper torso fit while preventing apron from slipping off shoulders....
Freedom of movement - plus full circle, maximum radiation protection. No other full circle radiation protection design approaches the level of comfort of the VestSkirt, which divides weight between t...
Medicine Products: